See more : Inspire Medical Systems, Inc. (INSP) Income Statement Analysis – Financial Results
Complete financial analysis of Fredun Pharmaceuticals Limited (FREDUN.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fredun Pharmaceuticals Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Daehan Steel Co., Ltd. (084010.KS) Income Statement Analysis – Financial Results
- BVZ Holding AG (BVZHF) Income Statement Analysis – Financial Results
- Piesat Information Technology Co., Ltd. (688066.SS) Income Statement Analysis – Financial Results
- Bangkok Chain Hospital Public Company Limited (BCH-R.BK) Income Statement Analysis – Financial Results
- Supreme Petrochem Limited (SPLPETRO.BO) Income Statement Analysis – Financial Results
Fredun Pharmaceuticals Limited (FREDUN.BO)
About Fredun Pharmaceuticals Limited
Fredun Pharmaceuticals Ltd. engages in the manufacture and sale of pharmaceuticals, neutraceuticals, herbal and dietary supplements. It also offers animal healthcare products. The company was founded by Nariman Bamansha Medhora on June 8, 1987 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.47B | 2.74B | 2.22B | 1.31B | 1.13B | 963.44M | 594.42M | 566.96M | 423.21M | 253.58M | 191.24M | 150.82M | 116.75M | 79.69M |
| Cost of Revenue | 2.76B | 2.18B | 1.84B | 1.07B | 870.36M | 648.54M | 421.87M | 414.77M | 296.60M | 168.26M | 136.94M | 100.56M | 87.33M | 35.16M |
| Gross Profit | 708.92M | 560.72M | 374.76M | 244.64M | 256.58M | 314.90M | 172.56M | 152.19M | 126.62M | 85.31M | 54.30M | 50.25M | 29.42M | 44.53M |
| Gross Profit Ratio | 20.45% | 20.44% | 16.90% | 18.61% | 22.77% | 32.68% | 29.03% | 26.84% | 29.92% | 33.64% | 28.39% | 33.32% | 25.20% | 55.88% |
| Research & Development | 13.42M | 67.00K | 85.00K | 303.00K | 62.00K | 1.00K | 1.70M | 0.00 | 0.00 | 0.00 | 10.60K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 52.97M | 30.13M | 21.18M | 16.56M | 15.09M | 21.60M | 16.21M | 15.71M | 7.42M | 8.95M | 8.80M | 6.63M | 2.58M | 6.07M |
| Selling & Marketing | 32.86M | 34.65M | 47.23M | 18.81M | 16.29M | 25.50M | 14.60M | 17.31M | 12.04M | 10.18M | 11.49M | 3.49M | 2.40M | 1.89M |
| SG&A | 344.89M | 64.78M | 68.41M | 35.37M | 31.38M | 47.10M | 30.80M | 33.03M | 19.46M | 19.14M | 20.29M | 10.12M | 4.97M | 7.96M |
| Other Expenses | 0.00 | 1.92M | 310.00K | 797.00K | 2.10M | 3.55M | 1.11M | 7.57M | 466.34K | 129.97K | 118.15K | 3.44M | 44.96M | 0.00 |
| Operating Expenses | 360.46M | 299.43M | 246.17M | 169.51M | 191.66M | 223.73M | 127.40M | 119.85M | 88.58M | 68.22M | 39.50M | 40.10M | 26.32M | 38.08M |
| Cost & Expenses | 3.12B | 2.48B | 2.09B | 1.24B | 1.06B | 872.28M | 549.27M | 534.62M | 385.17M | 236.49M | 176.44M | 140.66M | 113.65M | 73.23M |
| Interest Income | 137.00K | 1.49M | 4.49M | 910.00K | 832.57K | 494.55K | 407.29K | 267.88K | 168.05K | 303.06K | 2.30M | 182.94K | 300.65K | 66.50K |
| Interest Expense | 136.50M | 91.58M | 43.91M | 40.47M | 41.43M | 20.12M | 15.72M | 15.28M | 15.70M | 8.74M | 6.88M | 7.68M | 7.34M | 4.55M |
| Depreciation & Amortization | 37.96M | 28.09M | 21.57M | 20.04M | 18.79M | 13.30M | 12.85M | 11.36M | 8.04M | 5.46M | 5.26M | 4.90M | 3.54M | 3.17M |
| EBITDA | 377.66M | 296.00M | 154.25M | 93.72M | 86.86M | 105.88M | 58.67M | 39.03M | 45.47M | 19.96M | 16.68M | 13.05M | 8.49M | 8.31M |
| EBITDA Ratio | 10.90% | 10.75% | 7.35% | 8.05% | 7.60% | 9.66% | 9.41% | 8.60% | 9.27% | 8.20% | 9.34% | 11.49% | 8.12% | 10.43% |
| Operating Income | 364.26M | 251.78M | 117.29M | 73.88M | 64.64M | 90.54M | 32.96M | 22.26M | 18.35M | 5.19M | 4.54M | 3.91M | -2.39M | 596.70K |
| Operating Income Ratio | 10.51% | 9.18% | 5.29% | 5.62% | 5.74% | 9.40% | 5.54% | 3.93% | 4.34% | 2.05% | 2.37% | 2.59% | -2.05% | 0.75% |
| Total Other Income/Expenses | -149.74M | -92.46M | -51.65M | -52.27M | -39.98M | -29.54M | -17.70M | -5.40M | -80.69M | -43.33M | -48.52M | -11.98M | 0.00 | 0.00 |
| Income Before Tax | 214.52M | 175.09M | 86.00M | 32.07M | 24.95M | 61.62M | 26.42M | 22.26M | 18.35M | 5.19M | 4.54M | 467.23K | -2.39M | 596.70K |
| Income Before Tax Ratio | 6.19% | 6.38% | 3.88% | 2.44% | 2.21% | 6.40% | 4.44% | 3.93% | 4.34% | 2.05% | 2.37% | 0.31% | -2.05% | 0.75% |
| Income Tax Expense | 58.29M | 67.02M | 22.65M | 11.92M | 5.93M | 17.02M | 8.91M | 7.99M | 7.66M | 2.63M | 2.12M | 394.64K | 8.33M | 376.01K |
| Net Income | 156.23M | 108.07M | 63.35M | 20.15M | 19.02M | 44.60M | 17.51M | 14.27M | 10.70M | 2.56M | 2.42M | 72.59K | -2.39M | 220.70K |
| Net Income Ratio | 4.51% | 3.94% | 2.86% | 1.53% | 1.69% | 4.63% | 2.95% | 2.52% | 2.53% | 1.01% | 1.27% | 0.05% | -2.05% | 0.28% |
| EPS | 33.66 | 24.13 | 11.28 | 5.05 | 4.77 | 11.59 | 6.07 | 6.39 | 4.55 | 1.09 | 1.03 | 0.03 | -1.02 | 0.09 |
| EPS Diluted | 33.24 | 22.93 | 11.28 | 5.05 | 4.77 | 11.59 | 6.07 | 6.39 | 4.55 | 1.09 | 1.03 | 0.03 | -1.02 | 0.09 |
| Weighted Avg Shares Out | 4.64M | 4.48M | 5.62M | 3.99M | 3.99M | 3.85M | 2.88M | 2.35M | 2.35M | 2.35M | 2.35M | 2.35M | 2.35M | 2.38M |
| Weighted Avg Shares Out (Dil) | 4.70M | 4.71M | 5.62M | 3.99M | 3.99M | 3.85M | 2.88M | 2.35M | 2.35M | 2.35M | 2.35M | 2.35M | 2.35M | 2.38M |
No news found for: FREDUN.BO
Source: https://incomestatements.info
Category: Stock Reports